Shikonin promotes adriamycininduced apoptosis by upregulating caspase3 and caspase8 in osteosarcoma

Qing Yang1, Suoyuan Li2, Zeze Fu3

  • 1Department of Orthopedics, Nanjing Medical University Shanghai Tenth People's Hospital, Nanjing, Jiangsu 210029, P.R. China.

Insights

Shikonin (SK) enhances adriamycin (ADM) chemotherapy for drug-resistant osteosarcoma by promoting apoptosis. This combination therapy increases the expression of apoptosis-related proteins, offering a potential new treatment strategy.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Osteosarcoma is the most common primary bone malignancy.
  • Cancer cells develop resistance to chemotherapy drugs like adriamycin (ADM).
  • Shikonin (SK), derived from Chinese medicinal herbs, shows potential in cancer treatment.

Purpose of the Study:

  • To investigate the role and mechanism of SK in osteosarcoma chemotherapy.
  • To evaluate SK's effect on ADM resistance in osteosarcoma cells.

Main Methods:

  • Cell viability assessed using CCK-8 assay.
  • Protein expression of Bax, caspase-3, caspase-8, and PARP analyzed by Western blot.
  • Cell cycle and apoptosis analyzed via flow cytometry.

Main Results:

  • Combined SK and ADM treatment significantly reduced osteosarcoma cell survival in a dose- and time-dependent manner.
  • Increased expression of Bax, caspase-3, caspase-8, and PARP observed post-treatment.
  • Significant induction of apoptosis in osteosarcoma cells by the combined SK and ADM therapy.

Conclusions:

  • SK cooperates with ADM to enhance chemotherapy efficacy in osteosarcoma.
  • The mechanism involves the induction of caspase-3- and caspase-8-dependent apoptosis.
  • SK shows promise as an enhancer for treating drug-resistant osteosarcoma.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.0K